Get the Stockscreener App
10.27
2.38%
-0.25
Tempest Therapeutics Inc stock is traded at $10.27, with a volume of 36,150.
It is down -2.38% in the last 24 hours and up +8.68% over the past month.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
See More
Previous Close:
$10.52
Open:
$10.4
24h Volume:
36,150
Relative Volume:
0.52
Market Cap:
$45.51M
Revenue:
-
Net Income/Loss:
$-43.10M
P/E Ratio:
-1.0565
EPS:
-9.7212
Net Cash Flow:
$-36.82M
1W Performance:
-11.85%
1M Performance:
+8.68%
6M Performance:
+35.49%
1Y Performance:
-24.76%
1-Day Range:
$10.09
$10.47
1-Week Range:
$10.09
$11.98
52-Week Range:
$5.3495
$15.73
Tempest Therapeutics Inc Stock (TPST) Company Profile
Name
Tempest Therapeutics Inc
Sector
Industry
Phone
415-798-8589
Address
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.25 | 46.71M | 0 | -43.10M | -36.82M | -9.7212 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.97 | 109.29B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
466.95 | 62.13B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
582.06 | 61.40B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
817.76 | 51.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
313.88 | 34.68B | 4.56B | -176.77M | 225.30M | -1.7177 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-08-24 | Initiated | Jefferies | Buy |
Tempest Therapeutics Inc Stock (TPST) Latest News
Is Tempest Therapeutics Inc. stock cheap at current valuationRisk Management & Precise Entry and Exit Recommendations - newser.com
Published on: 2025-10-21 20:27:57 - newser.com
Can Tempest Therapeutics Inc. stock maintain growth trajectoryBear Alert & Safe Entry Point Identification - newser.com
How Tempest Therapeutics Inc. stock performs in interest rate cyclesMarket Growth Report & Safe Capital Growth Tips - newser.com
Should you wait for a breakout in Tempest Therapeutics Inc.2025 Performance Recap & Technical Entry and Exit Alerts - newser.com
Using flow based indicators on Tempest Therapeutics Inc.Gap Up & Entry Point Strategy Guides - newser.com
Published on: 2025-10-21 04:00:59 - newser.com
What’s next for Tempest Therapeutics Inc. stock price2025 Major Catalysts & Long Hold Capital Preservation Plans - newser.com
How to use Fibonacci retracement on Tempest Therapeutics Inc.Global Markets & Daily Technical Forecast Reports - newser.com
Will Tempest Therapeutics Inc. stock recover after recent dropEntry Point & Real-Time Buy Signal Alerts - newser.com
Portfolio Recap: How institutional buying supports Tempest Therapeutics Inc. stockMarket Growth Summary & High Accuracy Swing Entry Alerts - nchmf.gov.vn
What momentum indicators show for Tempest Therapeutics Inc. stockSwing Trade & Capital Efficiency Focused Ideas - nchmf.gov.vn
How Tempest Therapeutics Inc. stock benefits from global expansion2025 Risk Factors & Reliable Entry Point Alerts - nchmf.gov.vn
Will Tempest Therapeutics Inc. stock outperform Nasdaq indexJuly 2025 Reactions & Free Growth Oriented Trading Recommendations - newser.com
Real time social sentiment graph for Tempest Therapeutics Inc.July 2025 Fed Impact & Daily Stock Trend Reports - newser.com
Tempest Therapeutics (NASDAQ:TPST) Upgraded at Wall Street Zen - Defense World
About Us - FinancialContent
Is it time to cut losses on Tempest Therapeutics Inc.Weekly Stock Analysis & Community Verified Trade Signals - newser.com
Is Tempest Therapeutics Inc. stock reversal real or fakeQuarterly Portfolio Report & Technical Confirmation Alerts - newser.com
Technical signs of recovery in Tempest Therapeutics Inc.July 2025 Levels & Expert Verified Movement Alerts - newser.com
Is Tempest Therapeutics Inc. still worth holding after the dipJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - newser.com
What moving averages say about Tempest Therapeutics Inc.Dollar Strength & High Yield Equity Trading Tips - newser.com
Is Tempest Therapeutics Inc a good long term investmentGlobal Market Influence & Ride the Wave of Market-Beating Growth - earlytimes.in
Applying chart zones and confluence areas to Tempest Therapeutics Inc.July 2025 Levels & Weekly Momentum Stock Picks - newser.com
Tempest Therapeutics Inc Stock (TPST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.90%
0.69%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):